Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, translational and clinical research to prevent, treat and cure infectious diseases, including known and emerging infections of major global health importance such as influenza, SARS-CoV-2, HIV, and cancer-related infectious diseases. Applying an innovative multidisciplinary approach, VIDD houses three formal research programs that systematically pursue explicit goals aimed at eliminating the burden of death and disease from infection. These programs include Biostatistics, Bioinformatics and Epidemiology; Immunology and Vaccine Development; and Infectious Disease Sciences.
The Program Operations Director (POD) for the Immunology and Vaccine Development (IVD) Program provides oversight and direction for a research program of over 50 faculty and $300 million in research awards. The POD leverages broad experience in program leadership, strategic planning, research administration, federal regulatory requirements, financial planning & analysis, human resources management, training & development, research portfolio development including proposal writing, systems and process improvement, and communications. This position reports to the Associate Vice President (AVP) for VIDD.
This position works in partnership with program leadership, Principal Investigators (PIs) and VIDD’s Associate Vice President to independently plan and ensure the success of the program faculty in their research pursuits. The IVD Program Operations Director supervises managers to ensure consistent, efficient, and compliant administration of work units within the program: Research Administration, Regulatory Affairs, and Facilities & Operations, which includes oversight of the wet labs housed in the program. They ensure program strategy and objectives align with overall division and organizational priorities and provide input to division-level strategic planning.
1. Program Oversight (60%)
2. Strategic Planning (15%)
3. Faculty Support (25%)
Other duties as assigned.
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
The annual base salary range for this position is from $133,328 to $210,724, and pay offered will be based on experience and qualifications.
This position may be eligible for relocation assistance.
This position is not eligible for H-1B sponsorship at this time.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (12-22 days per year), paid sick leave (12-25 days per year), paid holidays (13 days per year), and paid parental leave (up to 4 weeks).
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide.
An independent, nonprofit organization, Fred Hutch also serves as UW Medicine’s cancer program. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Fred Hutchinson Cancer Center will accelerate the development, evaluation, and use of new cancer discoveries and treatments and will offer patients greater access to clinical trials, bringing research and clinical care closer together. For current patients the superior care you have come to expect from us will continue uninterrupted. For example, as part of the transition to Fred Hutch there will be no changes to your doctor or care team. Over the longer term, this update to our structure will enable us to improve patients’ care experiences and increase integration across your care team.
Fred Hutch will focus on integrating teams and operations over the coming weeks and months but you will see some new changes coming soon.
During the transition and afterward, high-quality patient care, research and operations will continue uninterrupted. Seattle Children's, an original SCCA alliance partner, will work in close partnership with Fred Hutchinson Cancer Center to advance breakthroughs in adult and pediatric oncology.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
![]()
Learn more about UW Medicine
Learn more about our research at Fred Hutch